The antiviral and antiproliferative effects of highly purified Escherichia coli-derived human interferons (IFNs) were examined in human melanoma cells (Hs294T). Antiproliferative activity was monitored by measuring inhibition of cell multiplication, and antiviral activity was determined by inhibition of herpes simplex virus type 1 replication. Treatment of cells with IFN--y in combination with IFN-aA Interferons (IFNs) have been grouped into three major classes based on differences in biological and chemical properties. IFN-cx (leukocyte) and IFN-1 (fibroblast) are generally produced by cells exposed to viruses or doublestranded RNA, whereas IFN-y (immune) is induced by lymphocytes in response to specific mitogenic stimuli (26). The biological activities of IFN--y have not been characterized as extensively as those of IFN-a or IFN-P; however, it appears that all three classes exhibit antiviral, immunomodulatory, and antiproliferative activities.
Interferons (IFNs) have been grouped into three major classes based on differences in biological and chemical properties. IFN-cx (leukocyte) and IFN-1 (fibroblast) are generally produced by cells exposed to viruses or doublestranded RNA, whereas IFN-y (immune) is induced by lymphocytes in response to specific mitogenic stimuli (26) . The biological activities of IFN--y have not been characterized as extensively as those of IFN-a or IFN-P; however, it appears that all three classes exhibit antiviral, immunomodulatory, and antiproliferative activities.
Interest in IFN--y in particular has been stimulated by recent studies which indicate that the antiproliferative effects of partially purified IFN-y may be superior to those of either IFN-a or IFN-P (8, 22) and that the molecular mechanisms of action of IFN-y may be different from those of the other IFNs (5, 6, 10, 12, 13, 18, 30) . Fleischmann has reported that mouse IFN--y and mouse IFN-a/P may potentiate each other with respect to inhibition of murine B-16 melanoma cell growth (12) . Similar potentiation of antiviral activity has been demonstrated with murine cells challenged with mengovirus (13) , encephalomyocarditis virus (30) , and herpes simplex virus type 1 (HSV-1) (30) . These earlier studies, however, were performed with, at best, partially purified IFN--y preparations known to be contaminated with lymphokines and, possibly, IFN-at and IFN-P, which could potentiate the IFN--y activities. This obstacle has been overcome with the cloning and expression of DNA encoding IFN-a (14, 16) , IFN-P1 (15) , and IFN--y (17) in Escherichia coli. Thus, sufficient quantities of highly purified IFN preparations are now available for extensive unambiguous comparative studies.
In this report, we have compared the effects of purified E.
coli-derived IFN-oxA, IFN-pl, and IFN-y either singly or in combination with each other with respect to (i) the growth of human melanoma cells and (ii) the replication of HSV-1 in the same cell line. Isobologram analysis of the data indicates that potentiation of IFN-induced antiproliferative and antivi-additivity and synergy but also provides a means of determining the degree of synergy obtained with the combinations. IFN-induced biological activities require the interaction of IFN with specific cellular receptors (1, 3) . At least two functional IFN receptor sites have been demonstrated on mouse (2) and human (4, 7, 18) [27] ), IFN-p,, and IFN--y were synthesized in E. coli (14) (15) (16) 17) and were more than 95% pure as determined by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and high-pressure liquid chromatography analysis (11, 28) . IFN titers were determined by cytopathic effect-inhibition microtiter assays. Ti-ters of IFN-aA and IFN-P, are expressed in international units based on human IFN research reference standards G023-901-527 and G023-902-527, respectively. IFN--y titers are expressed in laboratory units based on an internal laboratory standard. The titers of the IFN preparations which were obtained by standardizing against the appropriate reference standards are thus independent of the cell-virus system used. In this manner, the specific activities of IFNotA and IFN-P1 were ca. 1.5 x 108 to 2 x 108 U/mg, whereas that of IFN--y was 6 x 106 to 20 x 106 U/mg when assayed on HeLa cells challenged with vesicular stomatitis virus or on either A549 cells or Hs294T cells challenged with encephalomyocarditis virus.
Cells and viruses. The human melanoma cell line Hs294T was initiated and cloned at the Cell Culture Department, Naval Biosciences Laboratory, Oakland, Calif. The origin, characteristics, and cytogenetics of this line have been described previously (9 Hs294T cells were incubated with increasing concentrations of one class of IFN (IFN 1) alone, another class of IFN (IFN 2) alone, or combinations of both IFNs. Combinations of IFNs were prepared by mixing increasing concentrations of IFN 1 with fixed subinhibitory doses of IFN 2 and vice versa. The concentration of each IFN alone needed to inhibit cell growth by 50% varied with each experiment, reflecting changes in cell sensitivity to IFN-induced cell growth inhibition during cell passage, as well as possible variation in IFN assays. Therefore, to achieve internal consistency, it was necessary to generate the data for one isobologram from the same experiment, i.e., replicate cultures were treated with IFN 1, IFN 2, or combinations of IFNs 1 and 2 simultaneously to ensure that the concentrations of each IFN used in the combinations were all subinhibitory.
The concentrations of IFNs, either alone or in combination, required to achieve 50% inhibition of cell growth were calculated and normalized to fractional inhibitory concentrations (FICs). An FIC of 1.0 represents the concentration of each IFN, alone, required for 50% inhibition of cell growth. The concentrations of each IFN in the combinations were calculated as fractions of these values and used to construct the isobolograms in Fig. 2 . Any points obtained from combination treatments falling close to the line drawn between the FICs of 1.0 on the abscissa and ordinate would represent an additive effect. Points forming a concave curve below the line would indicate a supra-additive or synergistic response, whereas points forming a convex curve above this line would indicate a subadditive response implying inhibition or antagonism. The data from the treatment of cells with combinations of IFN--y and either IFN-cA or IFN-31 resulted in concave curves below the additivity line, indicating that these combinations elicited synergistic responses.
It is often difficult to differentiate between additivity and synergism. One interpretation (23) utilizes the FIC index, which is the sum of the FICs for the individual drugs used in each combination. A synergistic response is defined by an FIC index of less than 0.5, i.e., when 50% inhibition results from a combination of one-fourth or less of the concentration of each drug required to elicit the same effect if used individually. An FIC index greater than 0.5 defines an additive response. The FIC indices shown in Fig. 2 IFN treatments, cell cultures were treated with increasing concentrations of IFN-oxA, IFN-pl, and IFN--y alone or in combination and infected with HSV-1. As in the antiproliferative studies, replicate cultures were treated with each of the IFNs alone, or in combination with each other simultaneously, to ensure that the concentrations of each IFN used in the combinations were all subinhibitory. The dose-response curves in Fig. 3 Unlabeled IFN preparations which were analyzed in the biological studies described in Fig. 1 to 3 were used to compete with 35S-IFN-aA for receptor binding on Hs294T cells. Binding of labeled ligand was competitively inhibited in the presence of either unlabeled IFN-otA or IFN-31 (Fig.   7) . It appeared that IFN-P3 had a higher affinity for these cell surface receptors than IFN-o.A since it was more effective at competing with the labeled IFN. In contrast, IFN-y, even at a 320-fold excess of the amount necessary for a 50% reduction in cell growth (500 U/ml), was totally ineffective at competing with 35S-IFN-coA. (Fig. 1) . Assessment of relative potencies for anti-HSV-1 activities is more difficult. Considering the range of inherent experimental variation, the relative activities of IFN-axA, IFN-,B,, and IFN--y appeared to be quite similar, although the dose-response curves seemed to be linear for IFN-(xA and IFN-13 but not IFN--y (Fig. 3) . The same analysis, based on protein concentration, clearly indicates that IFN--y was less potent than either IFN-otA or IFN- Fig. 2 and 3 ; Table 1 ). Additionally, the magnitude of potentiation that we observed in our studies was greater than that reported previously (12, 13, 30) . Since our studies were performed with purified preparations of E. coli-derived IFNs, our results clearly demonstrate that potentiation of both cell growth-inhibitory and antiviral activities is due to the intrinsic properties of the IFN molecules themselves. (4), and yet treatment of Hs294T cells with combinations of these two classes of IFNs resulted in potentiation of biological activities ( Fig. 2 and 3) .
Substances that have identical modes of action generally interact in an additive manner. A synergistic response resulting from treatment with two agents in combination, as shown in this report with two types of IFNs, implies that these two agents exert their activities through distinct pathways. It We thank E. Rinderknecht and R. Harkins for preparations of purified IFN-y and IFN-,B,, respectively, and E. Hamilton and S. Apperson for technical assistance. We also thank J. Obijeski for LITERATURE CITED
